famotidine has been researched along with pirenzepine in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (26.32) | 18.7374 |
1990's | 10 (52.63) | 18.2507 |
2000's | 4 (21.05) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araki, I; Hashimoto, Y; Kimura, F; Kou, H; Kushikata, T; Matsuki, A; Murakawa, T; Sato, T; Takagi, H | 1 |
Chijiiwa, Y; Fujishima, H; Harada, N; Misawa, T; Nawata, H | 1 |
Honda, K; Kamato, T; Miyata, K; Nishida, A | 1 |
De Natale, F; De Natale, G; Marino, A | 1 |
Celle, G; Mela, GS; Savarino, V | 1 |
Mahachai, V; Thomson, AB | 1 |
Clausi, GG; Farinelli, M; Farroni, F; Fiorucci, S; Morelli, A; Pelli, MA; Santucci, L | 1 |
Canonica, GW; Caria, M; Cheli, R; Ciprandi, G; Pizzorno, G; Ruffoni, S; Scordamaglia, A | 1 |
Asai, M; Hashimoto, H; Hirota, K; Matsuki, A; Murakawa, T; Muraoka, M; Ogasawara, E; Sugihara, K; Takahashi, S | 1 |
Behrens, R; Hofbeck, M; Rupprecht, T; Scharf, J; Singer, H | 1 |
Meiser, BM; Muschiol, F; Nollert, G; Pfeiffer, M; Reichart, B; Reichenspurner, H; Uberfuhr, P; Vetter, HO; Wagner, F | 1 |
Busam, J; Garbe, WE | 1 |
Iwakawa, T; Kitayama, M; Matsuki, A; Miyahara, A; Murakawa, T; Okawa, H; Otomo, N | 1 |
Okhlobystin, AV; Sheptulin, AA | 1 |
Arai, H; Inoie, M; Marubuchi, S | 1 |
Muravtseva, OV; Vakhrushev, IaM | 1 |
Evseev, MA; Gostishchev, VK | 1 |
Evseev, MA; Golovin, RA; Ivakhov, GB | 1 |
Topliss, JG; Yoshida, F | 1 |
2 review(s) available for famotidine and pirenzepine
Article | Year |
---|---|
[Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
Topics: Antacids; Anti-Ulcer Agents; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Peptic Ulcer; Pirenzepine; Ranitidine; Thiazoles | 1989 |
Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Topics: Alprostadil; Antacids; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Enprostil; Famotidine; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Prostaglandins E, Synthetic; Ranitidine; Sucralfate; Thiazoles | 1987 |
4 trial(s) available for famotidine and pirenzepine
Article | Year |
---|---|
Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Topics: Adult; Circadian Rhythm; Drug Interactions; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Male; Middle Aged; Pirenzepine; Ranitidine; Thiazoles | 1988 |
[Does aging influence effect of pirenzepine alone or combination of pirenzepine and famotidine on gastric secretion during anesthesia and surgery?].
Topics: Adolescent; Adult; Aged; Aging; Depression, Chemical; Elective Surgical Procedures; Famotidine; Female; Gastric Juice; Humans; Intraoperative Period; Male; Middle Aged; Neuroleptanalgesia; Pirenzepine | 1995 |
Frequency of stress lesions of the upper gastrointestinal tract in paediatric patients after cardiac surgery: effects of prophylaxis.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Famotidine; Female; Heart Defects, Congenital; Humans; Incidence; Infant; Infant, Newborn; Male; Pirenzepine; Postoperative Complications; Prospective Studies; Stomach Ulcer; Stress, Physiological | 1994 |
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.
Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Ulcer Agents; Antilymphocyte Serum; Azathioprine; Cimetidine; Cyclosporine; Drug Combinations; Famotidine; Female; Heart Transplantation; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pirenzepine; Prednisone; Rats; Rats, Inbred BN | 1994 |
13 other study(ies) available for famotidine and pirenzepine
Article | Year |
---|---|
[Effect of M1 blocker or H2 blocker on gastric secretion during anesthesia and surgery].
Topics: Adolescent; Adult; Aged; Anesthesia, General; Depression, Chemical; Drug Synergism; Famotidine; Gastric Juice; Humans; Intraoperative Period; Middle Aged; Pirenzepine | 1992 |
Effects of combination therapy with pirenzepine and famotidine on tetragastrin-stimulated gastric secretion in humans.
Topics: Adult; Famotidine; Gastric Acid; Humans; Injections, Intravenous; Male; Pirenzepine; Stimulation, Chemical; Tetragastrin | 1991 |
Studies on the mechanism for the gastric mucosal protection by famotidine in rats.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Famotidine; Gastric Mucosa; Male; Pirenzepine; Rats; Rats, Inbred Strains; Regional Blood Flow; Stomach Ulcer; Tranexamic Acid | 1991 |
Low doses of H2 antagonists and interaction with anticholinergics.
Topics: Drug Synergism; Duodenal Ulcer; Famotidine; Gastric Acidity Determination; Humans; Pirenzepine; Ranitidine | 1989 |
Cytoprotective drugs: a new perspective in the treatment of adverse reactions to foods.
Topics: Adult; Aged; Analysis of Variance; Cell Division; Drug Combinations; Famotidine; Fatty Acids; Female; Food Hypersensitivity; Humans; Interferon-gamma; Interleukin-2; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Pirenzepine; Prostanoic Acids; Ranitidine; Thiazoles | 1988 |
[High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison].
Topics: Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Famotidine; Gastrointestinal Hemorrhage; Humans; Magnesium Hydroxide; Omeprazole; Peptic Ulcer Hemorrhage; Pirenzepine; Recurrence; Retrospective Studies; Survival Rate | 1994 |
[Effect of pirenzepine on gastric secretion during anesthesia and surgery].
Topics: Adolescent; Adult; Aged; Anesthesia, Inhalation; Drug Synergism; Famotidine; Gastric Juice; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Middle Aged; Neuroleptanalgesia; Pirenzepine | 1994 |
[Antisecretory effects of quamatel and gastrocepin in duodenal ulcer: comparison with intragastric pH-metry].
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Female; Follow-Up Studies; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Intestinal Secretions; Male; Middle Aged; Pirenzepine | 1998 |
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones | 1998 |
[The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Male; Middle Aged; Mucins; Muscarinic Antagonists; Omeprazole; Pirenzepine; Proton Pump Inhibitors; Ranitidine; Receptor, Muscarinic M1; Receptors, Muscarinic; Stomach Ulcer | 2002 |
[Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
Topics: Acute Disease; Anti-Ulcer Agents; Famotidine; Gastrointestinal Agents; Histamine H2 Antagonists; Humans; Octreotide; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Pirenzepine; Proton Pump Inhibitors | 2005 |
[Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
Topics: Antacids; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Pirenzepine; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2009 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |